Corechange has struck an exclusive agreement to integrate its technology into clinical information systems sold by GE Medical Systems. The integrated product will allow secure, single sign-on access to applications and information sources. The
Corechange has struck an exclusive agreement to integrate its technology into clinical information systems sold by GE Medical Systems. The integrated product will allow secure, single sign-on access to applications and information sources. The availability of a personalized user interface promises to improve efficiency and effectiveness when working with multiple computer applications, while addressing hospitals’ need to meet new regulatory requirements for privacy and security of patient information.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.